BRISTOL-MYERS TAKING ADVANTAGE OF AMERICAN STERILIZER LEVERAGED BUY-OUT
BRISTOL-MYERS TAKING ADVANTAGE OF AMERICAN STERILIZER LEVERAGED BUY-OUT bid to strengthen its Zimmer medical instruments business. Under the terms of the proposed agreement announced Nov. 5, Bristol-Myers will contribute $30 mil. in subordinated notes toward financing the $230 mil. bid for American Sterilizer. The buyout proposal comes from an investment group consisting of American Sterilizer senior management, First Boston, and investment banker Kelso & Co. The arrangement gives Bristol-Myers an option to acquire American Sterilizer's AMSCO/Hall powered surgical instruments div. for $55 mil. following completion of the tender offer, Bristol-Myers explained. Upon exercise of the option, Bristol-Myers said it will be allowed to credit $10 mil. of the purchase price to redemption of its notes. Bristol-Myers made the financing proposal shortly after American Sterilizer management announced in September that it was considering a move to take the company private, American Sterilizer indicated. Bristol-Myers had formerly been the exclusive distributor of a line of AMSCO/Hall instruments through its Zimmer medical device business.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth